Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1957 1
1958 2
1960 2
1961 1
1962 2
1963 2
1964 5
1965 4
1966 1
1969 1
1971 7
1972 1
1973 5
1974 2
1975 6
1976 8
1977 10
1978 12
1979 20
1980 11
1981 17
1982 17
1983 29
1984 22
1985 38
1986 39
1987 40
1988 29
1989 39
1990 48
1991 35
1992 49
1993 45
1994 68
1995 64
1996 78
1997 84
1998 99
1999 79
2000 144
2001 127
2002 156
2003 199
2004 249
2005 328
2006 401
2007 450
2008 517
2009 588
2010 704
2011 777
2012 992
2013 1064
2014 1262
2015 1293
2016 1385
2017 1485
2018 1795
2019 2033
2020 2480
2021 2814
2022 2040
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

21,737 results
Results by year
Filters applied: . Clear all
Page 1
Response.
Zhang M, Cheng Y. Zhang M, et al. Among authors: cheng y. Chest. 2022 Jul;162(1):e66-e67. doi: 10.1016/j.chest.2022.03.036. Chest. 2022. PMID: 35809959 No abstract available.
Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma.
Yamagishi R, Kamachi F, Nakamura M, Yamazaki S, Kamiya T, Takasugi M, Cheng Y, Nonaka Y, Yukawa-Muto Y, Thuy LTT, Harada Y, Arai T, Loo TM, Yoshimoto S, Ando T, Nakajima M, Taguchi H, Ishikawa T, Akiba H, Miyake S, Kubo M, Iwakura Y, Fukuda S, Chen WY, Kawada N, Rudensky A, Nakae S, Hara E, Ohtani N. Yamagishi R, et al. Among authors: cheng y. Sci Immunol. 2022 Jun 24;7(72):eabl7209. doi: 10.1126/sciimmunol.abl7209. Epub 2022 Jun 24. Sci Immunol. 2022. PMID: 35749514
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
Shi Y, Chen G, Wang X, Liu Y, Wu L, Hao Y, Liu C, Zhu S, Zhang X, Li Y, Liu J, Cao L, Cheng Y, Zhao H, Zhang S, Zang A, Cui J, Feng J, Yang N, Liu F, Jiang Y, Gu C; FURLONG investigators. Shi Y, et al. Among authors: cheng y. Lancet Respir Med. 2022 Jun 2:S2213-2600(22)00168-0. doi: 10.1016/S2213-2600(22)00168-0. Online ahead of print. Lancet Respir Med. 2022. PMID: 35662408
Protein Methylation in Diabetic Kidney Disease.
Cheng Y, Chen Y, Wang G, Liu P, Xie G, Jing H, Chen H, Fan Y, Wang M, Zhou J. Cheng Y, et al. Front Med (Lausanne). 2022 May 12;9:736006. doi: 10.3389/fmed.2022.736006. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35647002 Free PMC article. Review.
TNF-α/anti-TNF-α drugs and its effect on pregnancy outcomes.
Dai FF, Hu M, Zhang YW, Zhu RH, Chen LP, Li ZD, Huang YJ, Hu W, Cheng YX. Dai FF, et al. Among authors: cheng yx. Expert Rev Mol Med. 2022 Jun 10;24:e26. doi: 10.1017/erm.2022.18. Expert Rev Mol Med. 2022. PMID: 35687009 Review.
21,737 results
You have reached the last available page of results. Please see the User Guide for more information.